Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Taysha Gene Therapies Inc (NASDAQ: TSHA) was $2.61 for the day, down -5.27% from the previous closing price of $2.75. In other words, the price has decreased by -$5.27 from its previous closing price. On the day, 3.06 million shares were traded.
Ratios:
Our analysis of TSHA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.35 and its Current Ratio is at 5.35. In the meantime, Its Debt-to-Equity ratio is 1.13 whereas as Long-Term Debt/Eq ratio is at 1.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on June 27, 2024, initiated with a Outperform rating and assigned the stock a target price of $5.
On April 09, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $9.
Jefferies Downgraded its Buy to Hold on February 01, 2023, whereas the target price for the stock was revised from $14 to $1.50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 27 ’24 when Manning Paul B bought 1,333,333 shares for $2.25 per share. The transaction valued at 2,999,999 led to the insider holds 1,333,333 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 77.45 while its Price-to-Book (P/B) ratio in mrq is 9.70.
Stock Price History:
Over the past 52 weeks, TSHA has reached a high of $4.32, while it has fallen to a 52-week low of $1.05. The 50-Day Moving Average of the stock is 38.53%, while the 200-Day Moving Average is calculated to be 34.22%.
Shares Statistics:
A total of 205.05M shares are outstanding, with a floating share count of 176.26M. Insiders hold about 17.89% of the company’s shares, while institutions hold 75.84% stake in the company.
